BillionToOne, Inc.
BLLN
Rankning i aktier
#3440
BillionToOne, Inc. is a specialized diagnostics company that innovates by... BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
Aktiekurs
$103.00
Marknadsvärde
$4.86B
Förändring (1 dag)
-1.60%
Förändring (1 år)
-
Land
US
Handel BillionToOne, Inc. (BLLN)
Kategori
Healthcare
Aktiekurshistorik för BillionToOne, Inc. (BLLN)
Högsta slutkurs: $100.49 den 2026-10-01
Lägsta slutkurs: $106.24 den 2025-11-01
Lägsta slutkurs: $106.24 den 2025-11-01
Aktiekurshistorik för BillionToOne, Inc. från 2025 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | -1.85% |
| 2025 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $683.51 | 20.51% |
US
|
|
| $232.43 | 6.57% |
US
|
|
| $397.91 | 111.63% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $175.18 | 20.09% |
US
|
